About Services Profiles Press Contact

Jim Mellon

Founder and Executive Chairman

Burnbrae Group

Douglas, IM

Jim Mellon

WBM Holdings LLC

Jim’s Biography

View moreless

Jim Mellon is a British entrepreneur, investor and philanthropist with a broad range of financial interests. Through the company he founded in 1994, the Burnbrae Group, Jim has a diverse portfolio of investments in private and public companies, as well as significant real estate holdings in Germany and the Isle of Man.

Jim’s core investment principles and beliefs are the result of meticulous research and analysis of nascent industries or extensive changes in markets. He has frequently predicted emerging market trends and identified global industry developments at an early stage. In his book ‘Wake Up!’ he famously foresaw the financial crash of 2008.

His 2017 book ‘Juvenescence' sparked a rush of capital into the expanding field of aging research, resulting in the formation of Juvenescence, a cutting-edge biopharmaceutical business focused on the commercialisation of therapies to delay, stop, and reverse aging.

Most recently, Jim wrote ‘Moo’s Law’, a book that focuses on investment opportunities in cellular agriculture and the new agrarian revolution. Jim co-founded Agronomics... Jim Mellon is a British entrepreneur, investor and philanthropist with a broad range of financial interests. Through the company he founded in 1994, the Burnbrae Group, Jim has a diverse portfolio of investments in private and public companies, as well as significant real estate holdings in Germany and the Isle of Man.

Jim’s core investment principles and beliefs are the result of meticulous research and analysis of nascent industries or extensive changes in markets. He has frequently predicted emerging market trends and identified global industry developments at an early stage. In his book ‘Wake Up!’ he famously foresaw the financial crash of 2008.

His 2017 book ‘Juvenescence' sparked a rush of capital into the expanding field of aging research, resulting in the formation of Juvenescence, a cutting-edge biopharmaceutical business focused on the commercialisation of therapies to delay, stop, and reverse aging.

Most recently, Jim wrote ‘Moo’s Law’, a book that focuses on investment opportunities in cellular agriculture and the new agrarian revolution. Jim co-founded Agronomics Ltd. in order to invest in companies leading the way in this sphere, and is its largest investor.

Jim is a member of the Board of Trustees of the American Federation for Aging Research (AFAR), the Buck Institute for Research on Aging and the Biogerontology Research Foundation. He is an Honorary Fellow of Oxford University's Oriel College, where he has founded the Mellon Centre for Longevity. Jim also sits on the Advisory Board of the Center for the Future of Aging, part of the Milken Institute. moreless

Jim’s Newsfeed

The Grocer

Agronomics takes 47% stake in biotch firm Liberation Labs

Executive director and co-founder of Agronomics, Jim Mellon, described the investment as hugely exciting.

Business Insider

VitroLabs raises $46 million to build and scale the world's first pilot production of cell cultivate

Jim Mellon of Agronomics, which led the series A funding, says they are happy to continue their support of VitroLabs and its tissue engineering platform which produces high quality, sustainable leather.

View News Archive

Jim’s Background

Burnbrae Group

Founder and Executive Chairman

Jan 1990 - Present

Douglas, IM

The Burnbrae Group is a global investment company headquartered on the Isle of Man and focused on identifiable emerging trends. The company invests in the financial services, information technology, leisure, property, life sciences and mining sectors.

Juvenescence

Co-founder and Chairman

Oct 2016 - Present

Juvenescence is a biotech company that has brought together a coalition of the best and most experienced scientists, drug developers, physicians, and investors to create cutting-edge therapies and products to improve the way we age. The company works closely with researchers worldwide and aims to empower people to plan their life journey and live longer.

Charlemagne Capital

Founder

London, UK

Charlemagne Capital was founded by Jim in 2000 and was a venture capital business that specialised in the management of emerging market assets for clients. The business was acquired by Fiera Capital in 2018.

Mann Bioinvest

Founder and Co-chairman

2012 - Present

Douglas, IM

Mann Bioinvest provides independent portfolio advice based on thorough analysis of opportunities in the biopharma sector.

Regent Pacific

Founder

1992 - Present

Hong Kong, HK

Regent Pacific is an investment company that focuses on growth and value‐led investments in the healthcare sector as well as in late‐stage life sciences industries.

UraMin

Founder

2005 - 2007

Jim founded the uranium mining company, UraMin, alongside Stephen Dattels in 2005. It was sold to Areva in 2007.

Thornton Management

Co-founder

1984 - 1988

Hong Kong, HK

Jim headed operations in Hong Kong for fund management company, Thornton Management, after co-founding the business with Richard Thornton.

Griffin Thornton

Trainee Fund Manager

1979 - 1984

Jim started his career as a Trainee Fund Manager with Griffin Thornton after graduating from Oxford.

View allHide

Jim’s Gallery

Board Positions

SalvaRx Group PLC

Board Member and Chairman

Jun 2015 - Present

SalvaRx Group is a pharmaceutical development company. Their focus is the development of effective pharmaceuticals for oncology patients. The company was previously known as 3legs Resources PLC.

Charlemagne Capital

Board member

Mar 2006 - Present

Charlemagne Capital was acquired by Fiera Capital in 2018. Jim also serves as Board member at Charlemagne Capital UK Ltd and Charlemagne Capital Iom Ltd.

Buck Institute for Research on Aging

Trustee

Novato, CA, USA

The Buck Institute for Research on Aging is the world’s first firm devoted solely to research on aging. The company is committed to helping people live better, longer.

Condor Gold Plc

Non-Executive Director

Jul 2012 - Present

London, UK

Condor Gold is a mineral exploration company that focuses on gold exploration and development in Nicaragua, Central America. The company was admitted to the LSE and AIM Market in 2006 and has been listed on the TSX since 2018. Jim also serves on the Board of Condor Resources PLC.

Manx Financial Group PLC

Chairman

Feb 2009 - Present

Douglas, IM

Manx Financial Group PLC is a holding company based on the Isle of Man with subsidiaries that offer a range of financial services, including retail and commercial banking services, payment and money saving solutions, foreign exchange, wealth management and insurance.

Speymill Deutsche Immobilien Company PLC

Non-Executive Director

Speymill Deutsche Immobilien Co PLC was a real estate investment trust later acquired by Cerberus Capital Management. Jim also sits on the board of Speymill PLC.

View allHide

Advisory Roles

Milken Institute

Advisory Board Member, Center for the Future of Aging

Santa Monica, CA, USA

The Milken Institute is a non-profit global organization that supports people to build meaningful and healthy lives, in which they can access effective education and gainful employment whilst developing and contributing to their broader communities.

Other Business Interests

AgeX Therapeutics

Investor

Alameda, CA, USA

AgeX Therapeutics is a biotechnology company focused on the development of innovative medicines and the commercialization of newly emerging therapeutics targeting human aging.

Current Board Positions

Agronomics Limited

Co-Founder and Non-Executive Director

Apr 2019 - Present

Douglas, IM

Agronomics Limited is investment vehicle taking stakes in companies pioneering alternatives to meat and fish. The idea is to grow meat cleanly from cells and to avoid all the environmental and animal welfare consequences of traditional meat production.

Webis Holdings PLC

Non-Executive Director

Jan 2012 - Present

Douglas, IM

Webis Holdings PLC is a holding company with subsidiaries functioning in the global gaming and technology sectors.

Areva Resources Southern Africa Inc

Board member

Johannesburg, ZA

Areva Resources Southern Africa Inc is a global mining company established to acquire and develop uranium properties throughout the world.

Chelsea Avondale Limited

Non-Executive Director

2016 - Present

Chelsea Avondale Ltd. is a holding company founded with the goal of acquiring property and casualty insurance companies.

Bradda Head Holdings Ltd

Non-Executive Deputy Chairman

Douglas, IM

Bradda Head Holdings Ltd., formerly Life Science Developments, is a lithium exploration company based in Douglas, Isle of Man. Bradda Head focuses on Identifying and developing quality lithium assets.

Rivington Street Holdings PLC

Board member

London, UK

Rivington Street Holdings PLC is a financial and media services company.

Regent Pacific

Chairman

Hong Kong, HK

View allHide

Previous Board Positions

Portage Biotech

Non-Executive Director

Toronto, CA

Portage Biotech (NASDAQ: PRTG) is a clinical-stage immuno-oncology company dedicated to revolutionising research into cancer and the development of world-leading treatments that contribute significantly in helping cancer patients improve their quality of life.

FastForward Innovations Limited

Executive Co-Chairman

Saint Peter Port, GG

FastForward Innovations Limited's investment focus is on emerging, problem-solving, innovative technologies that will determine the future.

View allHide

Media

New Alternatives to Animal Protein

Panel discussion

Dec 2021

At the Bloomberg Technology Summit, Jim Mellon spoke to Senior Editor, Anne Riley Moffat, about new alternatives to animal protein.

The Longevity Forum: An Agricultural Revolution To Save Our World

Video

Nov 2021

In 2021 The Longevity Forum took place in Glasgow during the COP26 climate summit. This panel session on the future of food and agriculture was moderated by the forum’s co-founder Jim Mellon and included Cassandra Coburn, Editor in Chief The Lancet; Henry Dimbleby Co-founder Leon Restaurants; and Eugene Klerk Head of Global ESG Credit Suisse.

The Plantbased Business Hour

Podcast

Jun 2021

Elysabeth Alfano invited investor Jim Mellon on to The Plantbased Business Hour to talk about his predictions for the world’s food supply chain.

The IEA: The New Agrarian Revolution with Jim Mellon

Video interview

Mar 2021

Jim Mellon was invited by The Institute of Economic Affairs to discuss his book, Moo’s Law.

Robb Read Report: Silicon Valley takes on death

Featured

Apr 2021

Jim features in this article highlighting the steps taken by technology investors in pursuit of longevity and disease-free lives.

The Food Tech Show

Podcast

Mar 2021

Jim, in discussion with Michael Wolf, talks about developments in food technology and the future of cultured meat.

The Investor's Podcast Network

Podcast

Mar 2021

In this podcast, Jim talks to Trey Lockerbie about his new book, "Moo's Law" and the conversation expands into the possibilities of human longevity, sustainable energy and related investments.

Science, Technology and the Future

Interview

Aug 2019

Jim is interviewed by Adam Ford of Science, Technology and the Future at the 2019 Undoing Aging Conference in Berlin. He discusses the increase in investment in biotech medicine and longevity.

Loup TV

Interview

Nov 2020

Gene Munster interviews Jim for Loup TV. The pair discuss the possibility of longer life expectancy for human beings and maintaining quality of life as we age.

MoneyWeek

Interview

Nov 2020

Interviewed by Samantha Somerset Webb for MoneyWeek, Jim talks about his future investment themes, the environment and recommends where Britons should be investing their money.

View allHide

Interviews

Jim Mellon predicts the end of animal and dairy farming

Interviewee

Jul 2021

In this video Jim talks to Euronews about the prospect of an agrian revoultion, and how we can all be healthier for longer.

Publications

Moo's Law

Author

Dec 2020

Petersfield, UK

Jim has written Moo’s Law to help readers understand the landscape of investment in cultivated or plant-based proteins. He anticipates that global agriculture will be completely transformed by the growth of the cultivated meat technology industry over the next twenty years.

Juvenescence: Investing in the Age of Longevity

Author

Sep 2017

Sudbury, UK

In this book, co-authors Jim Mellon and Al Chalabi present a roadmap to longevity, analysing the latest technologies available and describing how to benefit from them.

View allHide

Memberships

Longevity Biotechnology Association

Founding Member

Nov 2021 - Present

Formed in 2021, the Longevity Biotechnology Association brings together leaders in gerotherapeutics and geroscience with the aim of developing therapies and medicines to extend healthspan and end age-related diseases.

Awards & Endorsements

American Federation for Aging Research

George E. and Marie J. Doty Award

New York, NY, USA

The American Federation for Aging Research has the provision of funding for biomedical research on aging at the heart of its mission. Jim was given the George E. and Marie J. Doty Award for his contribution to aging research.

Academic Appointments

Oriel College, University of Oxford

Honorary Fellow

Oxford, UK

Jim is an alumni of Oriel College, the fifth oldest of the University of Oxford’s colleges. Oriel was founded in 1326.

Speaking Engagements

Master Investor

Speaker, Master Investor Show 2019

Apr 2019

Jim presents on the main stage at the 2019 Master Investor Show. He offers the audience his perspective on market developments and thematic economic trends.

Charitable Interests

Lifeboat Foundation

Board member

Reno, NV, USA

The Lifeboat Foundation is a non-profit and non-governmental organization committed to promising scientific developments.

Jim’s Education

Oriel College, University of Oxford

Master's in Politics, Philosophy and Economics (PPE)

1976 - 1979

Ampleforth College